Introduction BDNF is a highly conserved member of the neurotrophin family of secreted proteins. It is synthesized at low levels in the central nervous system during development and at higher levels during the postnatal period [1, 2] . In the adult brain, BDNF is the most abundant and widely distributed neurotrophin [3] . It signals through the tropomyosinrelated kinase B (TrkB) receptor and activates phospholipase C gamma (PLC-g), mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3-K) intracellular signaling cascades [4, 5] . BDNF is functionally versatile, facilitating neuronal survival, differentiation, and synaptic connectivity during development, as well as synaptic plasticity and efficacy in the mature brain. The serendipitous finding that intracerebroventricular (ICV) delivery of BDNF reduced food intake and body weight in rats [6, 7] provided the first indication that this neurotrophin might participate in the regulation of feeding.
In the past decade, ensuing investigations in humans and rodents have further reinforced a paramount role for BDNF and TrkB in the regulation of energy balance. In mice, global BDNF haploinsufficiency, brain-specific BDNF depletion, or TrkB hypomorphic expression results in excessive feeding and body weight gain, accompanied by other features of the associated metabolic syndrome, including hyperleptinemia, hyperglycemia, and hyperinsulinemia [8] [9] [10] [11] (Table 1) . Moreover, selective targeting of the truncated TrkB.T1 receptor isoform, which has been suggested to limit neuronal responsiveness to BDNF, attenuates obesity in BDNF haploinsufficient mice [12] . Human studies also underscore the importance of this neurotrophin pathway. A de novo missense mutation in the TrkB gene hindering MAPK activation was identified in an individual exhibiting hyperphagia and severe obesity [13] . Furthermore, 100% of individuals afflicted with Wilms' tumor, aniridia, genitourinary anomalies, and mental retardation (WAGR) syndrome due to large truncations in chromosome 11 were obese by the time they reached 10 years of age when the deletion encompassed the Bdnf gene [14] . By contrast, only 20% of WAGR patients with intact Bdnf alleles exhibited obesity. Lastly, several studies have linked a common single nucleotide polymorphism in the human Bdnf gene (i.e., the Val66Met polymorphism) that impedes activity-dependent secretion and signaling of BDNF to higher body mass index [15] [16] [17] [18] [19] . These investigations include an association study of nearly 250,000 individuals that identified Bdnf as a genetic locus linked to obesity susceptibility in humans [17] .
Despite this body of evidence, questions remain regarding the true contribution of BDNF to the regulation of energy homeostasis in the mature animal. Is the hyperphagia observed in several models of BDNF and TrkB deficiency the consequence of corrupted satiation signaling or the result of perturbing the broad neurotrophic effects of BDNF? Specifically, could aberrant development of the feeding neurocircuitry or alterations in basic components of neuronal function in BDNF mutants lead to obesity as a side effect? Here, I review evidence addressing these questions and supporting a critical role for this pleiotropic neurotrophin in physiological mechanisms controlling nutrient intake and body weight. They include reports of functional interactions of BDNF with anorexigenic and orexigenic signaling pathways in the brain and evidence of appetite hormones with well-established roles in the regulation of energy balance having neurotrophic effects similar to those of BDNF.
BDNF and TrkB expression and responses to energy status in feeding control centers of the brain Food intake is a complex behavior governed by central homeostatic mechanisms balancing nutritional needs and caloric status. Consistent with a role in feeding regulation,
